Thirty immigrants were sworn in atop One World Trade Center, in a ceremony that featured a speech by the former U.S. attorney Preet Bharara.
NYS Entity Status
NYS Filing Date
JANUARY 04, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - ABOVE MY HEAD, INC.
Around the Web
- New Citizens Hold Their Heads High, 102 Floors Above New York
By LIZ ROBBINS - Tuesday Aug 15, 2017
- Food & Wine Magazine Will Leave New York for Alabama
By STEPHANIE STROM - Friday Jun 23, 2017
The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.
- Trucks that sell bulk meat in parking lots may head to NY
By Lisa Fickenscher - Saturday Sep 30, 2017
Zaycon Fresh, a meat seller that skips stores to sell its discounted steaks and pork chops directly out of trailer trucks, is eyeing the New York area — and says it’s close to raising $50 million to make it happen. The Spokane, Wash.-based outfit typically asks its mostly suburban and rural customers to meet its...
- Recalling Spygate wreckage, the original NY-Boston scandal
By Mark Cannizzaro - Wednesday Sep 6, 2017
Ten years ago “Spygate’’ consumed the NFL with a news cycle it wished never got started. It wrecked relationships, cost the Patriots draft picks and money, and forever tarnished the reputation of the franchise and its Hall of Fame-bound head coach, Bill Belichick. Eric Mangini, then the Jets coach, blew the whistle on the Patriots...
- NY man due in court in killings of mom, sister, 3rd woman
Sunday Aug 13, 2017
HEMPSTEAD, N.Y. (AP) — A man accused of bludgeoning his mother, sister and another woman to death after being kicked out of his home on New York's Long Island is headed to court.Suffolk County police say Vanderhall had a history of emotional problems, and his mother had gotten a protective order against him and had thrown him out of their Hempstead home.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]